IP Library Granted Patent US 10,711,288
Granted Patent B2
US 10,711,288 · App. 14/897,285 · Granted Jul 14, 2020

Methods of producing omega-hydroxylated fatty acid derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,711,288
App. No.
14/897,285
Granted
Jul 14, 2020
Kind
B2
Abstract

The disclosure relates to omega-hydroxylated fatty acid derivatives and methods of producing them. Herein, the disclosure encompasses a novel and environmentally friendly production method that provides omega-hydroxylated fatty acid derivatives at high purity and yield. Further encompassed are recombinant microorganisms that produce omega-hydroxylated fatty acid derivatives through selective fermentation.

Claims (28)

1. A recombinant microorganism engineered to express a CYP153A-reductase hybrid fusion polypeptide variant comprising a CYP153A ω-hydroxylase domain and a P450RhF reductase domain; wherein the hybrid fusion polypeptide variant has at least 91% sequence identity to SEQ ID NO: 6 and has one or more mutations selected from the group consisting of V141I, V141T, V141Q, V141G, V141M, V141L, R27L, R82D, R178N, A231T, N309R, N407A, V415R, T516V, P666A, P666D and A796V.

2. The recombinant microorganism of claim 1 , wherein the hybrid fusion polypeptide variant has a mutation at amino acid position 141 that is V141I or V141T.

3. The recombinant microorganism of claim 1 , wherein the hybrid fusion polypeptide variant is selected from the group consisting of:

(i) SEQ ID NO: 32;

(ii) SEQ ID NO: 34;

(iii) SEQ ID NO: 36;

(iv) SEQ ID NO: 38;

(v) SEQ ID NO: 40;

(vi) SEQ ID NO: 42;

(vii) SEQ ID NO: 44; and

(viii) SEQ ID NO: 46.

4. The recombinant microorganism of claim 3 , wherein the recombinant microorganism produces ω-hydroxy fatty acid derivatives selected from the group consisting of ω-hydroxy fatty acids and ω-hydroxy fatty acid methyl esters.

5. The recombinant microorganism of claim 1 , wherein the recombinant microorganism is engineered to further express a nucleic acid sequence encoding a polypeptide comprising an alcohol dehydrogenase of EC 1.1.1.1/2 or an alcohol oxidase of EC 1.1.3.13 or EC 1.1.3.20.

6. The recombinant microorganism of claim 5 , wherein the recombinant microorganism produces ω-hydroxy fatty acid derivatives selected from the group consisting of ω-oxo fatty acids and ω-oxo fatty acid methyl esters.

7. The recombinant microorganism of claim 5 , wherein the recombinant microorganism is engineered to further express a nucleic acid sequence encoding a polypeptide comprising an aldehyde dehydrogenase of EC 1.2.1.3/4/5 or an aldehyde oxidase of EC 1.2.3.1.

8. The recombinant microorganism of claim 7 , wherein the recombinant microorganism produces ω-hydroxy fatty acid derivatives that are α,ω-diacids or ω-carboxy fatty acid methyl esters.

9. The recombinant microorganism of claim 7 , wherein the recombinant microorganism is engineered to further express a nucleic acid sequence encoding a polypeptide comprising an acyl-CoA ligase of EC 6.2.1.3 or an acyl-CoA transferase of EC 2.8.3.6.

10. The recombinant microorganism of claim 9 , wherein the recombinant microorganism produces ω-hydroxy fatty acid derivatives that are α,ω-diesters.

11. The recombinant microorganism of claim 5 , wherein the recombinant microorganism is engineered to further express a nucleic acid sequence encoding a polypeptide comprising an amino transferase of EC 2.6.1 or an amine dehydrogenases of EC 1.4.9, EC 1.4.98 or EC 1.4.99.

12. The recombinant microorganism of claim 11 , wherein the recombinant microorganism produces ω-hydroxy fatty acid derivatives that are selected from the group consisting of ω-amino fatty acids and ω-amino fatty acid methyl esters.

13. The recombinant microorganism of claim 3 , wherein the recombinant microorganism is engineered to further express a nucleic acid sequence encoding a polypeptide comprising an alcohol dehydrogenase of EC 1.1.-.- and a carboxylic acid reductase of 1.2.99.

14. The recombinant microorganism of claim 13 , wherein ω-hydroxy fatty acid derivative is a α,ω-diol.

15. A cell culture comprising the microorganism of claim 1 , wherein said microorganism produces ω-hydroxy fatty acid derivatives selected from the group consisting of, ω-hydroxy free fatty acids; ω-hydroxy fatty acid methyl esters; ω-oxo fatty acids; ω-oxo fatty acid methyl esters; α,ω-diacids; α,ω-diols; ω-amino fatty acids; and ω-amino fatty acid methyl esters.

16. A method of producing a ω-hydroxy fatty acid derivative comprising:

(a) providing a cell culture of claim 15 ;

(b) adding a renewable feedstock containing a carbon source to said cell culture in a fermentation broth; and

(c) isolating a ω-hydroxy fatty acid derivative from said fermentation broth.

17. The method of claim 16 , wherein said carbon based renewable feedstock is selected from the group consisting of corn, sugar cane, sorghum, beet, switch grass, ensilage, straw, lumber, pulp, sewage, garbage, cellulosic urban waste, flu-gas, syn-gas, biomass hydrolysate, and carbon dioxide.

Assignments (4)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2019
From: REG LIFE SCIENCES, LLC
To: GENOMATICA, INC.
Reel/Frame 050695/0661 →